EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53

Juliana Calheiros, Vincenzo Corbo, Lucília Saraiva

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2023

DOI: 10.1016/j.bbcan.2023.188914 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023. Verfasst von Juliana Calheiros und 2 weiteren Autor:innen. Beteiligte Einrichtung: LAQV/REQUIMTE, Laboratόrio de Microbiologia, Departamento de Ciências Biolόgicas, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portu…. Hauptthemen laut MEDLINE: BRCA1 Protein, Pancreatic Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministério da Ciência, Tecnologia e Ensino Superior, Fondazione AIRC per la ricerca sul cancro ETS, Rede de Química e Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer (PC) is characterized by (epi)genetic and microenvironmental alterations that negatively impact the treatment outcomes. New targeted therapies have been pursued to counteract the therapeutic resistance in PC. Aiming to seek for new therapeutic options for PC, several attempts have been undertaken to exploit BRCA1/2 and TP53 deficiencies as promising actionable targets. The elucidation of the pathogenesis of PC highlighted the high prevalence of p53 mutations and their connection with the aggressiveness and therapeutic resistance of PC. Additionally, PC is associated with dysfunctions in several DNA repair-related genes, including BRCA1/2, which sensitize tumours to DNA-damaging agents. In this context, poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi) were approved for mutant BRCA1/2 PC patients. However, acquired drug resistance has become a major drawback of PARPi. This review emphasizes the importance of targeting defective BRCAs and p53 pathways for advancing personalized PC therapy, with particular focus on how this approach may provide an opportunity to tackle PC resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA1 ProteinPancreatic NeoplasmsHumansBRCA2 ProteinDrug Resistance, NeoplasmPoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) PolymerasesTumor Suppressor Protein p53

Stichwörter der Autor:innen

BRCA1/2Drug resistancePancreatic cancerTargeted therapyp53

Substanzen

BRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanPoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) PolymerasesTumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • LAQV/REQUIMTE, Laboratόrio de Microbiologia, Departamento de Ciências Biolόgicas, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal.
  • Department of Engineering for Innovation Medicine (DIMI), University and Hospital Trust of Verona, Verona, Italy; ARC-Net Research Centre, University and Hospital Trust of Verona, Verona, Italy.
  • LAQV/REQUIMTE, Laboratόrio de Microbiologia, Departamento de Ciências Biolόgicas, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal. Electronic address: lucilia.saraiva@ff.up.pt.

Förderung

  • Ministério da Ciência, Tecnologia e Ensino Superior
  • Fondazione AIRC per la ricerca sul cancro ETS
  • Rede de Química e Tecnologia
  • Fundação para a Ciência e a Tecnologia
  • Laboratório Associado para a Química Verde
  • Associazione Italiana per la Ricerca sul Cancro

Zitieren

APA

Calheiros, J., Corbo, V., & Saraiva, L. (2023). Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2023.188914

Vancouver

Calheiros J, Corbo V, Saraiva L. Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023. doi:10.1016/j.bbcan.2023.188914

BibTeX
@article{Calheiros2023,
  author = {Calheiros, Juliana and Corbo, Vincenzo and Saraiva, Lucília},
  title = {Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2023},
  doi = {10.1016/j.bbcan.2023.188914}
}
Kostenlos starten →